Indivior Pharmaceuticals annual revenue
2021
2022
2023
2024
2025
Indivior Pharmaceuticals Revenue Growth & History (INDV)
Indivior Pharmaceuticals reported $1.24B in revenue for fiscal 2025, an increase of 4.29% from the previous fiscal year.
View full Indivior Pharmaceuticals company overviewIndivior Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.24B | $51.0M | +4.29% |
| 2024 | 2024-12-31 | $1.19B | $95.0M | +8.69% |
| 2023 | 2023-12-31 | $1.09B | $192.0M | +21.31% |
| 2022 | 2022-12-31 | $901.0M | $110.0M | +13.91% |
| 2021 | 2021-12-31 | $791.0M | — | — |
Indivior Pharmaceuticals quarterly revenue
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $343.0M | $41.0M | +13.58% |
| Q1 2026 | 2026-03-31 | $317.0M | $51.0M | +19.17% |
| Q4 2025 | 2025-12-31 | $357.0M | $59.0M | +19.80% |
| Q3 2025 | 2025-09-30 | $314.0M | $7.0M | +2.28% |
| Q2 2025 | 2025-06-30 | $302.0M | $3.0M | +1.00% |
| Q1 2025 | 2025-03-31 | $266.0M | −$18.0M | −6.34% |
| Q4 2024 | 2024-12-31 | $298.0M | — | — |
| Q3 2024 | 2024-09-30 | $307.0M | — | — |
| Q2 2024 | 2024-06-30 | $299.0M | — | — |
| Q1 2024 | 2024-03-31 | $284.0M | — | — |
Indivior Pharmaceuticals revenue growth trends
Indivior Pharmaceuticals's latest reported quarter, Q2 2026, generated $343.0M in revenue, an increase of 13.58% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Indivior Pharmaceuticals source filings ↗